Peritonitis prevention in continuous ambulatory peritoneal dialysis

Area of Science:

• Nephrology
• Infectious Diseases
• Medical Technology

Background:

• Peritonitis is a major cause of morbidity in continuous ambulatory peritoneal dialysis (CAPD).
• Peritonitis rates are declining globally.
• Effective prevention strategies are crucial for CAPD patient outcomes.

Purpose of the Study:

• To review decisive and promising approaches for preventing peritonitis in CAPD.
• To discuss the impact of Y-set systems and flush-before-fill techniques.
• To explore future prevention measures for Staphylococcus aureus peritonitis.

Main Methods:

• Review of clinical results with reusable and single-use Y-set systems.
• Analysis of in vitro studies on flush-before-fill technique efficacy.
• Discussion of evidence on nasal carriers and Staphylococcus aureus peritonitis risk.
• Exploration of antibiotic prophylaxis, intraperitoneal IgG therapy, and staphylococcal vaccination.

Main Results:

• Y-set systems significantly reduce intraluminal contamination, especially by Staphylococcus epidermidis.
• The flush-before-fill technique can eliminate non-adherent microorganisms.
• Pre-CAPD nasal carriers are identified as high-risk for Staphylococcus aureus peritonitis.
• Mupirocin nasal application, IgG therapy, and vaccination are potential future measures.

Conclusions:

• New Y-set systems and flush-before-fill techniques are effective in reducing CAPD peritonitis.
• Targeting Staphylococcus aureus nasal carriage is a key future prevention strategy.
• Intraperitoneal IgG therapy and staphylococcal vaccination offer additional infection control avenues.